Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Diamondback Energy
FANG
$59B
| $53.1M | 0.1% |
822,168
-549,541
| -40% | -$37.3M |
|
227
Mohawk Industries
MHK
$9.23B
| $52.8M | 0.1% |
290,179
-120,795
| -29% | -$23.9M |
|
228
Neurocrine Biosciences
NBIX
$15.5B
| $52.7M | 0.1% |
1,325,374
+168,487
| +15% | +$8.14M |
|
|
CTXS
229
DELISTED
Citrix Systems Inc
CTXS
| $52.4M | 0.1% |
949,289
-68,816
| -7% | -$3.92M |
|
|
FOLD
230
DELISTED
Amicus Therapeutics
FOLD
| $52.2M | 0.1% |
3,734,506
-1,285,196
| -26% | -$20.2M |
|
231
Ultragenyx Pharmaceutical
RARE
$2.55B
| $52.2M | 0.1% |
541,689
+57,509
| +12% | +$6.58M |
|
232
Highwoods Properties
HIW
$3.46B
| $51.9M | 0.1% |
1,340,326
+716,387
| +115% | +$28.8M |
|
|
CPHD
233
DELISTED
Cepheid Inc
CPHD
| $51.5M | 0.1% |
1,139,419
+1,009,343
| +776% | +$53.9M |
|
234
State Street Technology Select Sector SPDR ETF
XLK
$120B
| $51.4M | 0.1% |
2,604,244
+605,338
| +30% | +$12.5M |
|
235
CALL
H&R Block
HRB
$6.62B
| $51.4M | 0.1% |
+1,420,000
| New | +$48.1M |
|
|
INXN
236
DELISTED
Interxion Holding N.V.
INXN
| $51.1M | 0.1% |
1,888,562
-544,936
| -22% | -$15.1M |
|
237
Steel Dynamics
STLD
$32.8B
| $50.9M | 0.1% |
2,962,651
+1,496,014
| +102% | +$29M |
|
|
SLCA
238
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $50.8M | 0.1% |
3,607,037
+1,585,766
| +78% | +$33.8M |
|
239
PG&E
PCG
$38.8B
| $50.4M | 0.1% |
954,590
+221,790
| +30% | +$11.3M |
|
|
FITB
240
Fifth Third Bancorp
FITB
$49.7B
| $50.3M | 0.1% |
2,659,982
-2,178,452
| -45% | -$44.3M |
|
241
Align Technology
ALGN
$11.5B
| $50.2M | 0.1% |
883,843
-15,625
| -2% | -$932K |
|
|
LPT
242
DELISTED
Liberty Property Trust
LPT
| $49.9M | 0.1% |
1,583,708
+1,181,198
| +293% | +$38.4M |
|
243
Sysco
SYY
$40.2B
| $49.6M | 0.1% |
1,272,182
+1,105,209
| +662% | +$42.2M |
|
244
Acadia Healthcare
ACHC
$2.59B
| $49.4M | 0.1% |
744,968
+83,559
| +13% | +$6.43M |
|
245
Archrock
AROC
$5.58B
| $49.3M | 0.1% |
2,741,593
+785,382
| +40% | +$18.8M |
|
|
ALDR
246
DELISTED
Alder Biopharmaceuticals
ALDR
| $49.3M | 0.1% |
1,505,099
+32,674
| +2% | +$1.39M |
|
247
NVIDIA
NVDA
$5.2T
| $49.2M | 0.1% |
+79,893,240
| New | +$43.2M |
|
|
SF
248
Stifel
SF
$12.2B
| $49.1M | 0.1% |
2,625,950
+2,265,790
| +629% | +$51.3M |
|
|
EMC
249
DELISTED
EMC CORPORATION
EMC
| $48.3M | 0.09% |
1,999,476
+619,689
| +45% | +$15.7M |
|
250
Affiliated Managers Group
AMG
$9.21B
| $48M | 0.09% |
280,954
+271,464
| +2,861% | +$53.4M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.